arrow_back Back to IPOs
info

Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

SM

Speciality Medicines

Listed SME BSE SME · Pharmaceuticals

Price Band

₹117.0–124.0

Issue Size

₹29.14 Cr

Lot Size

1,000 shares

Min Investment

₹248,000

GMP

+₹0.0 (0.0%)

Issue Price

₹124.0

calendar_month Important Dates

play_arrow
IPO Open Date
Fri, 20 Mar 2026
stop
IPO Close Date
Tue, 24 Mar 2026
assignment
Allotment Date
Wed, 25 Mar 2026
currency_rupee
Refund Initiation
Fri, 27 Mar 2026
account_balance
Credit of Shares
Thu, 26 Mar 2026
rocket_launch
Listing Date
Mon, 30 Mar 2026
Listing Price
₹124.0 +0.0%

bar_chart Subscription Status

info

Subscription data unavailable

trending_up Grey Market Premium (GMP)

GMP

₹0.0

GMP %

0.0%

Est. Listing

₹124.0

schedule Updated: 14 Jul 2026 15:52

business About the Company

Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals — including high-cost oral and injectable medications used to treat complex chronic conditions — across both domestic and international markets. The company’s portfolio includes a wide range of speciality pharmaceutical finished formulations such as capsules, creams, eye drops, gels, infusions, inhalations and inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, oral suspensions, sachets, suspensions, and tablets. Through wide-ranging distribution channels, the company has built a trusted reputation with clients across more than 20 states in India and over 35 countries worldwide. Speciality Medicines Limited offers over 650 products (as of July 31, 2024) under the unregistered category, with a particular focus on therapeutic areas like: Oncology Immunology Neurology Rare Diseases Additionally, the company’s product range includes human and animal medicines, vaccines, and plasma products — all sourced from manufacturers that comply with global quality standards like EUGMP and PICS. Global Expansion and Registrations As of July 31, 2024, Speciality Medicines Limited has: 1 plasma product registered in Bolivia 127 products under registration across 8 countries As of July 31, 2024, Speciality Medicines Limited employs a team of 20 permanent employees across various departments, contributing to the company’s smooth and efficient operations.

payments Company Financials (₹ Cr)

As of 2025-10-31

Period Ended 31 Oct 2025 31 Mar 2025 31 Mar 2024
Assets 45.57 39.98 22.68
Total Income 36.93 58.54 27.66
Profit After Tax 6.06 8.61 2.93
EBITDA 6.51 9.09 5.26
NET Worth 36.47 30.42 15.06
Reserves and Surplus 30.04 23.98 9.95
Total Borrowing 4.81 5.05 2.86

Key Ratios

EPS

₹13.38

NAV

₹47.26

ROE

37.85%

ROCE

33.39%

RoNW

28.30%

P/B Value

2.62

P/E Ratio

9.27

Market Cap

₹108.94 Cr

PAT Margin

14.77%

Debt/Equity

0.17

Promoters

Parth B Goyani and Goyani Sumit Babubhai

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat 12.68 2 Product Registration in International Markets and Product Development for sale in international markets 2.99 3 Funding for Marketing and Promotional Activities 1.66 4 To Meet Working Capital Requirements 8.00 5 General Corporate Purposes 0.25 6 Issue Expenses 3.57 Total 29.14

info Issue Details

Issue Type SME Book Built
Issue Size ₹29.14 Cr
Price Band ₹117.0 – ₹124.0
Issue Price ₹124.0
Lot Size 1,000 shares
Min Investment ₹248,000
Exchange BSE SME
Sector Pharmaceuticals
Open Date 20 Mar 2026
Close Date 24 Mar 2026
Allotment 25 Mar 2026
Listing Date 30 Mar 2026

pie_chart Investor Allocation

QIB (Institutional) 50%
NII / HNI 15%
Retail (RII) 35%

Registrar

domain Skyline Financial Services Pvt.Ltd.

Lead Managers / Book Running

account_balance Unistone Capital Pvt.Ltd.

timeline IPO Timeline

check

Open

20 Mar 2026

check

Close

24 Mar 2026

check

Allotment

25 Mar 2026

check

Listing

30 Mar 2026

1